# A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

> **NCT04752774** · PHASE1,PHASE2 · RECRUITING · sponsor: **Ipsen** · enrollment: 240 (estimated)

## Conditions studied

- Spasticity

## Interventions

- **BIOLOGICAL:** IPN10200
- **DRUG:** Placebo
- **BIOLOGICAL:** Dysport

## Key facts

- **NCT ID:** NCT04752774
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-29
- **Primary completion:** 2029-03-30
- **Final completion:** 2029-03-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04752774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04752774, "A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04752774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*